A nonprescription topical solution made with a new formulation of liquor carbonis distillate (LCD), known as Psorent, is significantly more effective than prescription-strength calcipotriol
cream in improving and controlling the symptoms of plaque psoriasis,
according to research findings presented at the American Academy of
Dermatology’s 2009 Annual Meeting. Significant efficacy differences
favoring LCD solution over a 12-week treatment phase were also
pronounced after treatment stopped, during a 6-week regression phase
that was the focus of the today’s presentation. The research, a
randomized, investigator-blind, active-controlled study of 60 adults
with moderate plaque psoriasis, was conducted by a team of
investigators at the Clinical Unit for Research Trials in Skin (CURTIS)
at Massachusetts General Hospital in Boston, Massachusetts.
Psorent is a new leave-on topical solution that has the proven efficacy of a
prescription medication but is available OTC. This aesthetically
advanced, quick-drying, solution is highly effective, easy and pleasant
to use, and may help increase patient satisfaction and compliance.
